Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Rakela

Showing results (131-140 of 150) with videos related to

Pageof 15
Sort By:
Mayo Clinic Proceedings|March 1, 1989
Intraoperative blood loss and patient and graft survival in orthotopic liver transplantation: their relationship to clinical and laboratory dataT L Motschman, H F Taswell, M E Brecher, et al.
Transplantation|August 15, 1997
Hepatitis C virus genotypes in liver transplant recipients: impact on posttransplant recurrence, infections, response to interferon-alpha therapy and outcomeT Gayowski, N Singh, I R Marino, et al.
Journal of Viral Hepatitis|January 11, 2008
Hepatic steatosis in chronic hepatitis C: baseline host and viral characteristics and influence on response to therapy with peginterferon alpha-2a plus ribavirinK R Reddy, S Govindarajan, P Marcellin, et al.
Mayo Clinic Proceedings|October 1, 1990
Long-term versus short-term treatment with recombinant interferon alfa-2a in patients with chronic hepatitis B: a prospective, randomized treatment trialJ Rakela, J R Wood, A J Czaja, et al.
Transplantation|August 1, 1988
Efficacy of ganciclovir in liver and kidney transplant recipients with severe cytomegalovirus infectionC V Paya, P E Hermans, T F Smith, et al.
Hepatology (Baltimore, Md.)|August 1, 1997
The prediction of risk of recurrence and time to recurrence of hepatocellular carcinoma after orthotopic liver transplantation: a pilot studyJ W Marsh, I Dvorchik, M Subotin, et al.
Journal of Viral Hepatitis|June 24, 2006
Selection of different 5' untranslated region hepatitis C virus variants during post-transfusion and post-transplantation infectionJ F Gallegos-Orozco, J I Arenas, H E Vargas, et al.
Liver Transplantation and Surgery : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 1, 1996
Transjugular intrahepatic portosystemic shunt in patients with end-stage liver disease: results in 85 patientsN Jabbour, A B Zajko, P D Orons, et al.
Transplantation|February 11, 1998
Effects of immunotherapy on experimental immunodeficiency-related lymphoproliferative diseaseP S Randhawa, T L Whiteside, A Zeevi, et al.
The Journal of Infectious Diseases|February 1, 1997
Distribution of infecting hepatitis C virus genotypes in end-stage liver disease patients at a large American transplantation centerH E Vargas, L F Wang, T Laskus, et al.
Pageof 15

Showing results (131-140 of 150) with videos related to

Sort By:
Pageof 15
Mayo Clinic Proceedings|March 1, 1989
Intraoperative blood loss and patient and graft survival in orthotopic liver transplantation: their relationship to clinical and laboratory dataT L Motschman, H F Taswell, M E Brecher, et al.
Transplantation|August 15, 1997
Hepatitis C virus genotypes in liver transplant recipients: impact on posttransplant recurrence, infections, response to interferon-alpha therapy and outcomeT Gayowski, N Singh, I R Marino, et al.
Journal of Viral Hepatitis|January 11, 2008
Hepatic steatosis in chronic hepatitis C: baseline host and viral characteristics and influence on response to therapy with peginterferon alpha-2a plus ribavirinK R Reddy, S Govindarajan, P Marcellin, et al.
Mayo Clinic Proceedings|October 1, 1990
Long-term versus short-term treatment with recombinant interferon alfa-2a in patients with chronic hepatitis B: a prospective, randomized treatment trialJ Rakela, J R Wood, A J Czaja, et al.
Transplantation|August 1, 1988
Efficacy of ganciclovir in liver and kidney transplant recipients with severe cytomegalovirus infectionC V Paya, P E Hermans, T F Smith, et al.
Hepatology (Baltimore, Md.)|August 1, 1997
The prediction of risk of recurrence and time to recurrence of hepatocellular carcinoma after orthotopic liver transplantation: a pilot studyJ W Marsh, I Dvorchik, M Subotin, et al.
Journal of Viral Hepatitis|June 24, 2006
Selection of different 5' untranslated region hepatitis C virus variants during post-transfusion and post-transplantation infectionJ F Gallegos-Orozco, J I Arenas, H E Vargas, et al.
Liver Transplantation and Surgery : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 1, 1996
Transjugular intrahepatic portosystemic shunt in patients with end-stage liver disease: results in 85 patientsN Jabbour, A B Zajko, P D Orons, et al.
Transplantation|February 11, 1998
Effects of immunotherapy on experimental immunodeficiency-related lymphoproliferative diseaseP S Randhawa, T L Whiteside, A Zeevi, et al.
The Journal of Infectious Diseases|February 1, 1997
Distribution of infecting hepatitis C virus genotypes in end-stage liver disease patients at a large American transplantation centerH E Vargas, L F Wang, T Laskus, et al.
Pageof 15